125 related articles for article (PubMed ID: 38262874)
1. Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.
Halimi H; Mirzazadeh S; Kalantar K; Hajimaghsoodi M; Ramzi M; Farjadian S
Hum Immunol; 2024 Mar; 85(2):110750. PubMed ID: 38262874
[TBL] [Abstract][Full Text] [Related]
2. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
[TBL] [Abstract][Full Text] [Related]
3. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
4. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
5. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
[TBL] [Abstract][Full Text] [Related]
6. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
Misra MK; Prakash S; Moulik NR; Kumar A; Agrawal S
Hum Immunol; 2016 Jan; 77(1):41-46. PubMed ID: 26472014
[TBL] [Abstract][Full Text] [Related]
7. The impact of KIR-HLA genotype on hepatitis B virus clearance in Iranian infected individuals.
Shah-Hosseini A; Jafari M; Mohammadi A; Sanaei R; Alavian SM; Doosti-Irani A; Nooradeh Keykavousi M; Tajik N
Med Microbiol Immunol; 2017 Dec; 206(6):463-470. PubMed ID: 29032460
[TBL] [Abstract][Full Text] [Related]
8. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
9. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
[TBL] [Abstract][Full Text] [Related]
10. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
Akhtari M; Farazmand A; Mahmoudi M; Akbarian M; Ahmadzadeh N; Mirkazemi Z; Mostafaei S; Jamshidi AR
Lupus; 2016 Oct; 25(11):1244-53. PubMed ID: 26989167
[TBL] [Abstract][Full Text] [Related]
11. Association of killer-cell immunoglobulin-like receptor genes with acute myelogenous leukaemia.
Alavianmehr A; Mansouri M; Ramzi M; Faghih M; Monabati A; Arandi N; Faghih Z; Farjadian S
Int J Immunogenet; 2020 Dec; 47(6):512-521. PubMed ID: 32767509
[TBL] [Abstract][Full Text] [Related]
12. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.
Ashouri E; Rajalingam K; Barani S; Farjadian S; Ghaderi A; Rajalingam R
Sci Rep; 2021 Apr; 11(1):7932. PubMed ID: 33846431
[TBL] [Abstract][Full Text] [Related]
14.
Machado-Sulbaran AC; Ramírez-Dueñas MG; Navarro-Zarza JE; Muñoz-Valle JF; Mendoza-Carrera F; Baños-Hernández CJ; Parra-Rojas I; Montoya-Buelna M; Sánchez-Hernández PE
J Immunol Res; 2019; 2019():6808061. PubMed ID: 30723749
[TBL] [Abstract][Full Text] [Related]
15. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
16. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
[TBL] [Abstract][Full Text] [Related]
17. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
[TBL] [Abstract][Full Text] [Related]
18. The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis.
Jalalvand M; Beigmohammadi F; Soltani S; Ehsan S; Rajabkhah S; Madreseh E; Akhtari M; Jamshidi A; Farhadi E; Mahmoudi M; Nafissi S
Clin Neurol Neurosurg; 2024 Mar; 238():108171. PubMed ID: 38422742
[TBL] [Abstract][Full Text] [Related]
19. KIR2DS3 is associated with protection against acute myeloid leukemia.
Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
[TBL] [Abstract][Full Text] [Related]
20. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
